From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy.
Saved in:
| Title: | From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy. |
|---|---|
| Authors: | Pinto, E.1,2 (AUTHOR), Lione, L.3 (AUTHOR), Compagnone, M.1 (AUTHOR), Paccagnella, M.3 (AUTHOR), Salvatori, E.3 (AUTHOR), Greco, M.3 (AUTHOR), Frezza, V.3 (AUTHOR), Marra, E.3 (AUTHOR), Aurisicchio, L.1,3 (AUTHOR), Roscilli, G.3 (AUTHOR), Conforti, A.1,3 (AUTHOR) conforti@takisbiotech.it |
| Source: | Journal of Translational Medicine. 1/4/2025, Vol. 23 Issue 1, p1-16. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14795876 |
|---|---|
| DOI: | 10.1186/s12967-024-06052-3 |